African genomics startup 54gene raises $25M to expand precision medicine capabilities
Less than 3% of genetic material used in global pharmaceutical research is from Africa. The staggering gap is quite surprising because Africans and people of African descent are reported to be more genetically diverse than any other population.
Since launching in 2019, African genomics startup 54gene has been at the forefront of bridging this divide in the global genomics market. Today, the company has secured $25 million in Series B funding to bolster its efforts.
This round comes a year after the company, founded by Dr Abasi Ene-Obong, raised $15 million in Series A and two years after closing a $4.5 million seed round.
In total, 54gene has raised more than $45 million since its inception. Continue reading
Image: 54gene
The new CAMON 18 Premier brings together the best of the CAMON series, such as…
South Africa’s communications minister said today that this week’s massive social media outage of Facebook…
At the first Google for Africa event held today, October 6, 2021, global Internet giant,…
On Thursday, July 22, 2021, the Central Bank of Nigeria (CBN) revealed that the pilot…
FNB South Africa, one of the country’s top lenders, has announced today the launch of…
Google plans to invest up to $50 million in African early and growth-stage startups via…